Showing 61 - 80 results of 4,058 for search '"Thrombolysis"', query time: 0.14s Refine Results
  1. 61

    Impact of Bradykinin Generation During Thrombolysis in Ischemic Stroke by Maxime Gauberti, Maxime Gauberti, Fanny Potzeha, Denis Vivien, Denis Vivien, Sara Martinez de Lizarrondo

    Published 2018-07-01
    “…The present review aims at summarizing current evidence linking thrombolysis, bradykinin generation, and neurovascular damage.…”
    Get full text
    Article
  2. 62
  3. 63
  4. 64
  5. 65

    Choices Regarding Thrombolysis Are Modified by the Way to Transfer the Messages by Jingjing Gong, Yan Zhang, Hongyan Gao, Wei Wei, Jing Lv, Hongyun Liu, Yonghua Huang

    Published 2017-11-01
    “…Although thrombolysis is the most effective medical treatment for acute ischemic stroke, many stroke patients eligible for thrombolysis miss this treatment as a result of delay or refusal by the patients and/or their proxies. …”
    Get full text
    Article
  6. 66

    Intravenous Thrombolysis, Time Window, Dosage, and Off-Label by Kavian Ghandehari, Sharife Shahedi, Zahra Valipour, Mohammad Reza Sobhani, Hojat Salehian, Shokat Nazemian, Masumeh Rezae

    Published 2018-11-01
    “…Despite the development of Intravenous thrombolysis with tissue Plasminogen Activator (IVtPA) guidelines in each affiliated stroke center, protocol violations may be observed in each hospital with IVtPA facilities. …”
    Get full text
    Article
  7. 67

    Gender and thrombolysis therapy in stroke patients with incidence of dyslipidemia by Brice Blum, Leah Wormack, Mason Holtel, Alexandria Penwell, Shyyon Lari, Brittany Walker, Thomas I. Nathaniel

    Published 2019-01-01
    “…Whether there is a gender difference in exclusion criteria for the use of recombinant tissue plasminogen activator (rtPA) or thrombolysis therapy in an acute ischemic stroke subpopulation with dyslipidemia is yet to be investigated. …”
    Get full text
    Article
  8. 68

    Cortical myoclonus during IV thrombolysis for ischemic stroke by Carla Bentes, Rita Peralta, Pedro Viana, Carlos Morgado, Teresa P. Melo, José M. Ferro

    Published 2014-01-01
    “…Despite the multiple potential pathophysiological mechanisms for the relationship between thrombolysis and epileptic activity, seizures during this procedure are scarcely reported. …”
    Get full text
    Article
  9. 69
  10. 70

    Multidisciplinary Approach to Decrease In-Hospital Delay for Stroke Thrombolysis by Sang-Beom Jeon, Seung Mok Ryoo, Deok Hee Lee, Sun U. Kwon, Seongsoo Jang, Eun-Jae Lee, Sang Hun Lee, Jung Hee Han, Mi Jeong Yoon, Soo Jeong, Young-Uk Cho, Sungyang Jo, Seung-Bok Lim, Joong-Goo Kim, Han-Bin Lee, Seung Chai Jung, Kye Won Park, Min-Hwan Lee, Dong-Wha Kang, Dae Chul Suh, Jong S. Kim

    Published 2017-05-01
    “…Background and Purpose Decreasing the time delay for thrombolysis, including intravenous thrombolysis (IVT) with tissue plasminogen activator and intra-arterial thrombectomy (IAT), is critical for decreasing the morbidity and mortality of patients experiencing acute stroke. …”
    Get full text
    Article
  11. 71
  12. 72
  13. 73
  14. 74
  15. 75
  16. 76
  17. 77
  18. 78
  19. 79

    Alteplase or tenecteplase for thrombolysis in ischemic stroke: An illustrated review by Annie Zhu, Phavalan Rajendram, Eric Tseng, Shelagh B. Coutts, Amy Y. X. Yu

    Published 2022-08-01
    “…Abstract Intravenous thrombolysis is a standard of care treatment for patients with acute ischemic stroke. …”
    Get full text
    Article
  20. 80

    Quality indicators of intravenous thrombolysis from North India by Akanksha Grace William, Aman Pannu, Mahesh Pundlik Kate, Vineeth Jaison, Leenu Gupta, Smrithi Bose, Rajeshwar Sahonta, Ivy Sebastian, Jeyaraj Durai Pandian

    Published 2017-01-01
    “…Background: Data on intravenous (IV) thrombolysis using tissue plasminogen activator (tPA) are limited from low- and middle-income countries. …”
    Get full text
    Article